Marshall Wace’s Applied Therapeutics APLT Stock Holding History

Marshall Wace’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-337,389	Closed	-$33.7K	–	3168
2025 Q4	$33.7K	Sell	337,389 -2,205,299	-87%	-$1.4M	﹤0.01%	2803
2025 Q3	$1.53M	Buy	2,542,688 +998,497	+65%	+$470K	﹤0.01%	1744
2025 Q2	$479K	Buy	1,544,191 +236,810	+18%	+$91.6K	﹤0.01%	2165
2025 Q1	$641K	Hold	1,307,381	–	–	﹤0.01%	1966
2024 Q4	$1.12M	Buy	1,307,381 +773,377	+145%	+$4.85M	﹤0.01%	1680
2024 Q3	$4.54M	Buy	+534,004	New	+$3.15M	0.01%	1031
2024 Q1	–	Sell	-258,144	Closed	-$865K	–	2411
2023 Q4	$865K	Buy	+258,144	New	+$642K	﹤0.01%	1522

Marshall Wace's APLT Position: Q1 2026 in Review

Marshall Wace sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 337,389 shares — an estimated $33.7K sold.

Marshall Wace first reported a position in APLT in Q4 2023 and held it in 7 quarters. The position peaked at $4.54M in Q3 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

Marshall Wace reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
Marshall Wace sold 337,389 Applied Therapeutics shares in Q1 2026, an estimated $33.7K.
Marshall Wace first reported a position in Applied Therapeutics in Q4 2023 and held it in 7 quarters.
Marshall Wace's Applied Therapeutics position peaked at $4.54M in Q3 2024.
0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.